Total’s Grandpuits refinery in France will be converted into a zero-crude platform for the production of biofuels and bioplastic. The platform will comprise of three new industrial units: a bio-refinery, a bioplastics plant and a plastics recycling unit.

Under the terms of the agreement, Myokardia will acquire Myokardia’s mavacamten, a potential first-in-class cardiovascular medicine used for the treatment of obstructive hypertrophic cardiomyopathy, a chronic heart disease. The move is expected to further strengthen Bristol Myers Squibb’s portfolio, pipeline and scientific capabilities.

Under a Letter of Intent (LOI) signed between Chandra Asri and Vopak, both the companies will set up a joint venture company for collaborating in the industrial infrastructure business in Cilegon, Indonesia.

Biopharma Excellence’s merger with Pharmalex will strengthen the service providing firm’s existing operations in biopharma services. Pharmalex also has plans to develop the Biopharma Excellence brand into a key service line which will focus on providing high value services in biopharmaceuticals and integrated product development.

Perstorp has introduced the world’s first partly renewable carboxylic acids – 2-Ethylhexanoic Acid Pro and Valeric Acid Pro with a renewable content of 25 % and 20 % respectively. The oxo acids are expected to lower carbon footprint and also support the sustainable sourcing of renewable raw material.

Global Data’s recent survey revealed that the top management of biopharma companies in most parts of the world are positive about their annual revenue in Q3 2020 in the background of Covid-19 as compared to Q1.

With the acquisition, Gelest has now become a wholly owned subsidiary of Mitsubishi Chemical America. Mitsubishi Chemical Corporation also has plans to set up a post-merger integration office in Gelest to supervise the company’s operations.

Diosna Dierks & Söhne’s new pharmaceutical technical centre, ‘Diosna Process Lab’ offers various plant options and a wide range of possibilities for experimental implementation. Due to the global pandemic, the company has arranged a virtual tour of the technical centre for interested customers.

Under the terms of the agreement, Lyondell Basell and Sasol will form a 50:50 JV through which Lyondell Basell will acquire 50 % of Sasol’s selected assets in Louisiana for 2 billion dollars. The new JV will be operational under the name Louisiana Integrated Polyethylene JV.

Sibur will make use of 34 kt of recycled plastics every year to produce the green PET granules at its Polief site in Blagoveshchensk. The move aims to meet the growing demand of eco-friendly PET packaging and is in line with the company’s 2025 Sustainability Strategy.